The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone

Molecular and Cellular Endocrinology

Volumn 167, Issue 1-2, 2000, Pages 11-21

  McCulloch, Daniel R ^a   Harvey, Mark ^a   Herington, Adrian C ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

ADAM (a disintegrin and metalloprotease domain); Androgen; Integrin; Metalloprotease; Metastasis; Prostate cancer

Indexed keywords

A DISINTEGRIN AND METALLOPROTEASE DOMAIN; ANDROGEN; ANDROSTANOLONE; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, NORTHERN; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMAZANS; HUMAN; MALE; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STANOLONE; SUPPORT, NON-U.S. GOV'T; TETRAZOLIUM SALTS; TUMOR CELLS, CULTURED;

EID: 0034714890     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(00)00305-1     Document Type: Article

References (38)

1. Albini A., Melchiori A., Santi L., Liotta L.A., Brown P.D., Stetler-Stevenson W.G. Tumour cell invasion is inhibited by TIMP-2. J. Natl. Cancer Inst. 83:1991;775-779.
2. Black R.A., Rauch C.T., Kozlosky C.J., Peshon J.J., Slack J.L., Wolfson M.F., et al. A metalloproteinase disintegrin that releases turriour necrosis factor-a from cells. Nature. 385:1997;729-733.
3. Campbell C.L., Savarese D.M., Quesenberry P.J., Savarese T.M. Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: predominance of vascular endothelial growth factor. Int. J. Cancer. 80:1999;868-874.
4. Chopin L., Herington A.C. The growth hormone and insulin-like growth factor axis in prostate cancer. Clin. Biochem. Rev. 20:1999;3-16.
5. Cohen P., Peehl D.M., Graves H.C.B., Rosenfeld R.G. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. Endocrinology. 142:1994;407-415.
6. Cornwall G.A., Hsia N. ADAM7, a member of the ADAM (a disintegrin and metalloprotease) gene family is specifically expressed in the mouse anterior pituitary and epididymis. Endocrinology. 138:1997;4262-4272.
7. Emi M., Katagiri T., Harad Y., Saito H., Inazawa J., Ito I., et al. A novel metalloprotease/disintegrin-like gene at 17q2l.3 is somatically rearranged in two primary breast cancers. Nature Genet. 5:1993;151-157.
8. Fiers W. Tumour necrosis factor characterisation at the molecular, cellular and in vivo level. FEBS Lett. 285:1991;199-212.
9. Folkman J., Klagsburn M. Angiogenic factors. Science. 135:1987;442-447.
10. Fowlkes J.L., Thrailkill K.M., Serra D.M., Suzuki K., Nagase H. Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog. Growth Factor Res. 6:1995;255-263.
11. Gilpin B.J., Loechel F., Mattei M., Engvall E., Albrechtsen R., Wewer U.M. A novel, secreted form of human ADAM 12 (meltrin α) provokes myogenesis in vivo. J. Biol. Chem. 273:1998;157-166.
12. Huovila A., Almeida E.A.C., White J.M. ADAMs and cell fusion. Curr. Opinion Cell. Biol. 8:1996;692-699.
13. Iwamura M., Sluss P.M., Casamento J.B., Cockett T.K. Insulin-like growth factor 1: action and receptor characterisation in human prostate cancer cell lines. Prostate. 22:1993;243-252.
14. Izumi Y., Hirata M., Hasuwa H., Iwamoto R., Umata T., Mitado T., et al. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17:1998;7260-7272.
15. Jia L., Shimokawa K., Bjarnason J.B., Fox J.W. Snake venom metalloproteinases: structure, function and relationship to the ADAMS family of proteins. Toxicon. 34:1995;1269-1276.
16. Kratzscmar J., Lum L., Blopel C.P. Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence. J. Biol. Chem. 271:1996;4593-4596.
17. Lalani E.N., Stubbs A., Stamp G.W.H. Prostate cancer; the interface between pathology and basic scientific research. Sem. Cancer Biol. 8:1997;53-59.
18. Leavesley D.I., Schwartz M.A., Rosenfeld M., Cheresh D.A. Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signalling mechanisms. J. Cell. Biol. 121:1993;168-170.
19. Lee C., Sutkowski D.M., Sensibar J.A., Zelner D., Kim I., Amsel I., et al. Regulation of proliferation and production of prostate specific antigen in androgen-sensitive prostate cancer cells, LNCaP, by dihydrotestosterone. Endocrinology. 1316:1995;796-803.
20. Lin M.F., Meng T.C., Rao P.S., Chang C., Shonthal A.H., Lin F. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines. J. Biol. Chem. 273:1998;5939-5947.
21. Lunn C.A., Fan K., Dalie B., Miller K., Zavodny P.J., Narula S.K., Lundell D. Purification of ADAM 10 from bovine spleen as a TNFα convertase. FEBS Lett. 400:1997;333-335.
22. Millichip M.I., Dallas D.J., Wu E., Dale S., McKie N. The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem. Biophys. Res. Comm. 235:1998;594-598.
23. Montgomery B.T., Young C.Y.F., Bilhartz D.L., Andrews P.E., Prescott J.L., Thompson N.F., et al. Hormonal regulation of prostate specific antigen (PSA) glycoprotein in the human prostate adenocarcinorna cell line, LNCaP. Prostate. 21:1992;63-73.
24. Moss M.L., Catherine J., Milla M.E., Burkhart W., Carter L., Chen W., et al. Cloning of a disintegrin metalloprotease that processes precursor tumour-necrosis factor-α Nature. 385:1997;733-736.
25. Murphy G., Docherty A.J.P. The matrix metalloproteases and their inhibitors. J. Resp. Cell. Mol. Biol. 7:1992;120-125.
26. Nagase H. Activation mechanisms of matrix metalloproteinases. J. Biol. Chem. 378:1997;151-160.
27. Nakhla A.M., Rosner W. Characterization of a ALVA-41 cells, a new human prostaticcancer cell line. Steroids. 59:1994;586-589.
28. Patel I.R., Attur M.G., Patel R.N., Stuchin S.A., Abagyan R.A., Abramson S.B., Amin A.R. TNF-α convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-α J. Immunol. 160:1998;4570-4579.
29. Primakoff P., Myles D.G. The ADAM gene family: surface proteins with adhesion and protease activity. Trends in Genet. 16:(2):2000;83-87.
30. Roghani M., Becherer J.D., Moss M.L., Atherton R.E., Erdjument-Bromage H., Arribas J., et al. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J. Biol. Chem. 274:1999;3531-3540.
31. Rosendahl M.S., Ko S.C., Long D.L., Brewer M.T., Rosenzweig B., Hedl E., et al. Identification and characterisation of a pro-tumour necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J. Biol. Chem. 272:1997;24588-24593.
32. Simon K.O., Nutt E.M., Abraham D.G., Rodan G.A., Duong L.T. The αvβ3 integrin regulates α5β1-mediated cell migration toward fibronectin. J. Biol. Chem. 272:1997;29380-29389.
33. Springman E.B., Angleton E.L., Birkedal-Hansen H., Wart H.E. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a cys731 activesite zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc. Natl. Acad. Sci. USA. 87:1990;364-368.
34. Telford N.A., Hogan A., Franz C.R., Schultz G.A. Expression of genes for insulin and insulin-like growth factors and receptors in early postimplantation mouse embryo and embryonal carcinoma cells. Mol. Reprod. Develop. 26:1990;81-92.
35. Wolfsberg T.G., Primakoff P., Myles D.G., White J.M. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: muitipotential functions in cell-cell and cell-matrix interactions. J. Cell. Biol. 131:1995;275-278.
36. Wu E., Croucher P.I., McKie N. Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haernatological malignancies. Biochem. Biophys. Res. Comm. 235:1997;137-442.
37. Yeh C.H., Peng H.C., Huang T.F. Accutin, a new disintegrin, inhibits angiogenisis in vitro and in vivo by acting as integrin alphaVbeta3 antagonist and inducing apoptosis. Blood. 92:1998;3268-3276.
38. Zhang X., Kamata T., Yokoyoma K., Puzon-McLaughlin W.P., Takada Y. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin αvβ3. J. Biol. Chem. 273:1998;7345-7350.